Show Notes
In this episode of The GLP-1 Podcast Show, I speak with Dr. Ashley Koff, registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot, about weight health in the GLP-1 era. She explains why body composition matters more than total weight, how digestion and hydration shape nutrition outcomes, why protein advice must be personalized, and how clinicians can support more sustainable metabolic health. Listen now on all major platforms.
"Weight composition, including the type, amount, and location of bone, muscle, fat, and water, provides a more meaningful signal about health than total weight alone."
Meet the guest: Dr. Ashley Koff https://www.linkedin.com/in/ashley-koff is a registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot: The Personalized System for Optimal Weight Health. She also serves as Nutrition Course Director for the Integrative and Functional Medicine Fellowship at the Susan Samueli Integrative Health Institute. Her work focuses on personalized nutrition, weight health optimization, metabolic health, practitioner education, and helping patients make better, sustainable choices. Listen to Dr. Ashley Koff on The GLP-1 Podcast Show, available on all major platforms.
What you will learn: (00:00) Highlight (00:59) Introduction (03:58) Weight health (06:39) Success markers (08:59) Tracking trends (14:23) Functional status (20:49) Nutrition priorities (30:35) Future care
The GLP-1 Podcast Show is trusted and supported by innovative companies like:
- WiseVAs (https://www.wisevas.io/) - Elevate (https://elevateagents.ai/) - Zentrix Insights (https://zentrixinsights.com/) - ZentrixOS (https://zentrixos.com/)
๐๐ถ๐๐๐ฒ๐ป ๐ผ๐ป ๐๐ฝ๐ฝ๐น๐ฒ ๐ฃ๐ผ๐ฑ๐ฐ๐ฎ๐๐๐, ๐ฆ๐ฝ๐ผ๐๐ถ๐ณ๐ ๐ผ๐ฟ ๐ฎ๐ป๐ ๐บ๐ฎ๐ท๐ผ๐ฟ ๐ฝ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
More from The GLP-1 Podcast Show
In this episode of The GLP-1 Podcast Show, I speak with Dr. Anders Fink-Jensen, Professor of Psychiatry at the University of Copenhagen and a consultant psychiatrist, about the emerging role of GLP-1 receptor agonists in addiction treatment. We examine the clinical observations that initiated this research, findings from a randomized trial of semaglutide for alcohol use disorder, possible effects on craving, dosing considerations, and the evidence still needed before broader clinical use. Listen now on all major platforms.
In this episode of The GLP-1 Podcast Show, I speak with Dr. Michelle Gordon, a physician board-certified in obesity medicine and CEO of Thrive Span Medical, about obesity care for women in midlife. We discuss how GLP-1 therapy fits into long-term disease management, why slower weight reduction, adequate protein, resistance training, hydration, and fiber matter, and how hormonal changes may affect weight, cognition, and metabolic health. Dr. Gordon also explains when bariatric surgery remains appropriate and why obesity should be treated as a complex chronic disease. Listen now on all major platforms.
In this episode of The GLP-1 Podcast Show, I speak with Dr. Jon Campbell, Associate Professor of Medicine at Duke University, about the changing science of GIP and glucagon. We examine GIP physiology, glucagon signaling, weight-independent metabolic effects, multi-receptor agonism, and variability in treatment response. Discover how emerging pharmacology could shape more precise obesity treatment. Listen now on all major platforms.
In this episode of The GLP-1 Podcast Show, I speak with Dr. Timothy Garvey, Endowed Professor of Medicine at the University of Alabama at Birmingham, about complication-centric care for Adiposity-Based Chronic Disease. We examine current obesity guidelines, medication selection according to complications, what the key unmet clinical need is in obesity care, and the role of second-generation GLP-1 medications in type 2 diabetes. Listen now on all major platforms.
In this episode of The GLP-1 Podcast Show, I speak with Dr. Christopher Kramer, Chief of the Cardiovascular Division at the University of Virginia Health, about how GLP-1 and GIP therapies are reshaping the treatment of obesity-related heart failure. We explore cardiac remodeling, adipose tissue reduction, cardiovascular outcomes, and the mechanisms behind improved patient health. Listen now on all major platforms!